Literature DB >> 27367480

Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension.

Dirk Bandorski1, Harilaos Bogossian, Anja Ecke, Christoph Wiedenroth, Ekkehard Gruenig, Nicola Benjamin, Matthias Arlt, Werner Seeger, Eckhard Mayer, Ardeschir Ghofrani, Reinhard Hoeltgen, Henning Gall.   

Abstract

BACKGROUND: Several studies have analyzed arrhythmias in patients with pulmonary hypertension (PH) and increased P-wave duration was identified as a risk factor for development of atrial fibrillation (AF).
METHODS: We retrospectively analyzed the incidence of arrhythmias in patients with an initial diagnosis of PH during long-term follow-up and assessed the prognostic value of electrocardiography (ECG) data. Data from 167 patients were analyzed (Dana Point Classification: Group 1: 59 patients, Group 2: 28 patients, Group 3: 39 patients, Group 4: 41 patients). Clinical, 6-min-ute walk distance test, echocardiography and right heart catheterization data were collected, and baseline/follow-up ECGs were analyzed.
RESULTS: Baseline ECGs revealed sinus rhythm in 137 patients. Thirteen patients had newly onset AF during follow-up. In 30 patients, baseline ECG showed AF. Patients with baseline AF showed higher atrial diameters and higher right atrial pressure. Patients with P-wave du-ration > 0.11 s had shorter survival. Other ECG parameters (PQ-interval, QRS-width, QT-/ /QTc-interval) were not associated with survival. Mean survival times were 79.4 ± 5.4 months (sinus rhythm), 64.4 ± 12.9 months (baseline AF) and 58.8 ± 8.9 months (newly onset AF during follow-up) (p = 0.565).
CONCLUSIONS: Atrial fibrillation predict adverse prognosis in patients with PH and a longer P-wave (> 0.11 s) is associated with shorter survival time.

Entities:  

Keywords:  arrhythmia; atrial fibrillation; electrocardiogram; pulmonary hypertension

Mesh:

Year:  2016        PMID: 27367480     DOI: 10.5603/CJ.a2016.0044

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  10 in total

1.  Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.

Authors:  Benjamin Strauss; Yassine Sassi; Carlos Bueno-Beti; Zeki Ilkan; Nour Raad; Marine Cacheux; Malik Bisserier; Irene C Turnbull; Erik Kohlbrenner; Roger J Hajjar; Lahouaria Hadri; Fadi G Akar
Journal:  J Mol Cell Cardiol       Date:  2018-11-28       Impact factor: 5.000

Review 2.  [Arrhythmias in patients with pulmonary hypertension and chronic lung disease].

Authors:  Dirk Bandorski; Reinhard Höltgen; Ardeschir Ghofrani; Viktoria Johnson; Jörn Schmitt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-08-22

3.  Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management.

Authors:  Brett Wanamaker; Thomas Cascino; Vallerie McLaughlin; Hakan Oral; Rakesh Latchamsetty; Konstantinos C Siontis
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

4.  ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension.

Authors:  Marcin Waligóra; Anna Tyrka; Piotr Podolec; Grzegorz Kopeć
Journal:  Biomed Res Int       Date:  2018-04-10       Impact factor: 3.411

5.  Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact.

Authors:  Valentina Mercurio; Grace Peloquin; Khalil I Bourji; Nermin Diab; Takahiro Sato; Blessing Enobun; Traci Housten-Harris; Rachel Damico; Todd M Kolb; Stephen C Mathai; Ryan J Tedford; Carlo G Tocchetti; Paul M Hassoun
Journal:  Pulm Circ       Date:  2018-03-26       Impact factor: 3.017

6.  ECG pre-hospital teletransmission by emergency teams staffed with an emergency physician and paramedics and its impact on transportation and hospital admission.

Authors:  Joanna Sowizdraniuk; Jacek Smereka; Jerzy Robert Ladny; Alexander Kaserer; Krzysztof Palimonka; Kurt Ruetzler; Agnieszka Skierczynska; Lukasz Szarpak
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.889

7.  ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.

Authors:  Tomasz Adam Michalski; Joanna Pszczola; Anna Lisowska; Malgorzata Knapp; Bozena Sobkowicz; Karol Kaminski; Katarzyna Ptaszynska-Kopczynska
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

8.  Improvement in the electrocardiograms associated with right ventricular hypertrophy after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Authors:  Takahiko Nishiyama; Seiji Takatsuki; Takashi Kawakami; Yoshinori Katsumata; Takehiro Kimura; Masaharu Kataoka; Hikaru Tsuruta; Yuji Itabashi; Mitsushige Murata; Shinsuke Yuasa; Yoshiyasu Aizawa; Keiichi Fukuda
Journal:  Int J Cardiol Heart Vasc       Date:  2018-05-25

9.  Prognostic impact of red blood cell distribution width in pulmonary hypertension patients: A systematic review and meta-analysis.

Authors:  Jie Liu; Jiao Yang; Shuanglan Xu; Yun Zhu; Shuangyan Xu; Li Wei; Panpan Qian; Yuanyuan Lv; Chunfang Zhang; Xiqian Xing; Yishu Deng
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

10.  The prediction of right atrial pressure using electrocardiogram: a novel approach.

Authors:  Marzieh Mirtajaddini; Nasim Naderi; Maryam Chenaghlou; Sepideh Taghavi; Ahmad Amin
Journal:  ESC Heart Fail       Date:  2021-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.